论文信息 - Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines - 字舞流文

Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines

A. Ardizzoni | M. Tiseo | A. Mutti | P. Carbognani | P. Petronini | R. Alfieri | E. Barocelli | C. Fumarola | M. Bonelli | P. Mozzoni | G. Graiani | F. Quaini | L. Ampollini | A. Cavazzoni | M. Galetti | D. Madeddu | E. Galvani | Daniele Cretella | S. La Monica | F. Saccani